NCT04456413: A trial that was reported late by Hackensack Meridian Health
This trial has reported, although it was 224 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT04456413 |
|---|---|
| Title | Phase II Randomized Study of Convalescent Plasma From Recovered COVID-19 Donors Collected by Plasmapheresis as Treatment for Subjects With Early COVID-19 Infection |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Nov. 6, 2020 |
| Completion date | April 29, 2021 |
| Required reporting date | April 29, 2022, midnight |
| Actual reporting date | Dec. 9, 2022 |
| Date last checked at ClinicalTrials.gov | March 28, 2025 |
| Days late | 224 |